Highbridge Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-45,290
Closed -$5.78M 534
2018
Q3
$5.78M Buy
45,290
+43,413
+2,313% +$5.16M 0.14% 179
2018
Q2
$203K Sell
1,877
-109,618
-98% -$11.9M ﹤0.01% 825
2018
Q1
$11.8M Buy
111,495
+26,213
+31% +$3.04M 0.19% 122
2017
Q4
$9.99M Sell
85,282
-136,009
-61% -$15.4M 0.18% 160
2017
Q3
$25.2M Buy
221,291
+120,324
+119% +$13.9M 0.38% 59
2017
Q2
$12.6M Sell
100,967
-138,023
-58% -$16.4M 0.19% 132
2017
Q1
$28.3M Sell
238,990
-55,469
-19% -$6.29M 0.41% 50
2016
Q4
$29.5M Buy
294,459
+85,561
+41% +$9.17M 0.53% 41
2016
Q3
$26.4M Buy
208,898
+43,911
+27% +$5.43M 0.42% 48
2016
Q2
$19.3M Buy
164,987
+107,080
+185% +$12.1M 0.31% 83
2016
Q1
$6M Buy
+57,907
New +$5.6M 0.1% 239
2015
Q4
Sell
-36,336
Closed -$3.31M 1862
2015
Q3
$3.31M Sell
36,336
-49,864
-58% -$5M 0.05% 400
2015
Q2
$9.14M Sell
86,200
-83,431
-49% -$9.23M 0.12% 199
2015
Q1
$19.4M Sell
169,631
-287,359
-63% -$32.8M 0.27% 105
2014
Q4
$50.3M Sell
456,990
-108,198
-19% -$11.4M 0.64% 30
2014
Q3
$55.2M Buy
565,188
+78,339
+16% +$7.71M 0.73% 23
2014
Q2
$49.1M Buy
486,849
+412,464
+554% +$40.2M 0.6% 42
2014
Q1
$6.83M Buy
+74,385
New +$6.86M 0.09% 232
2013
Q3
Sell
-30,448
Closed -$2.4M 1550
2013
Q2
$2.21M Buy
+30,448
New +$2.28M 0.02% 467

Other funds holding ZBH

Highbridge Capital Management's ZBH Position: Q4 2018 in Review

Highbridge Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 45,290 shares — an estimated $5.78M sold.

Highbridge Capital Management first reported a position in ZBH in Q2 2013 and held it in 19 quarters. The position peaked at $55.2M in Q3 2014. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

  • Highbridge Capital Management reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 45,290 Zimmer Biomet shares in Q4 2018, an estimated $5.78M.
  • Highbridge Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 19 quarters.
  • Highbridge Capital Management's Zimmer Biomet position peaked at $55.2M in Q3 2014.
  • 871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.